MENU
Anatomy
Anesthesiology
Biochemistry
Biomedical Informatics
Biophysics
Cell Biology
Clinical Cases
Dentistry
Dermatovenerology
Emergency Medicine
Family Medicine
Forensic Medicine
Gynecology and Obstetrics
Histology and Embryology
History of Medicine
Human Genetics
Hygiene
Infectious Diseases
Internal Medicine
Medical Deontology and Philosophy
Medical Psychology
Microbiology and Immunology
Neurology
Occupational Medicine
Oncology
Ophthalmology
Orthopaedics
Otorhinolaryngology
Pathology
Pathophysiology
Pediatrics
Pharmacology and Experimental Toxicology
Physical and Rehabilitation Medicine
Physiology
Psychiatry
Radiology
Social Medicine
Surgery
Toxicology
Research papers
Clinical research paper
Preclinical research paper
Sponsored articles
Archive » 1999 » 4 » | Archive » Medical field » Research papers » Clinical research paper » Archive » Medical field » Fields » Gynecology and Obstetrics » Archive » Medical field » Fields » Oncology »

Survival of Patients with Ovarian Cancer

 
Abstract:

This post is also available in: enEnglish slSlovenščina (Slovenian)

Data from 282 patients who were first treated for epithelial ovarian malignoma at the Institute of Oncology and Gynecological clinic in Ljubljana between 1990 and 1992 were analysed retrospectively. The patients were followed through 1997. The survival rates were determinated by Kaplan­Meier method. For establishment of hazard ratios Cox analysis was used. The five-year survival rates for different prognostic factors are as follows: 74 % for borderline patients and 38 for patients with carcinomas; by stage (I-IV) 88, 48, 26 and 12 %; by cancer grades (1-3) 69, 49, 26 %, respectively. Concerning age 50 older patients survive five years in 31 %, but younger in 61 %. The group with the diameter of residual implants after surgery smaller then 1 cm has 73 % five-year survival, but the other group 18 %. After multivariate analysis the prognostic factors which were still significant are: stage, age high­er then 50, the diameter of residual implants after first surgery greater than 1 cm, and type of pri­mary treatment for the whole cohort and the one of higher stages (III and IV) The type of prima­ry treatment was not significant for the group with the lower stages (I and II) of cancer. An understanding of the influence of these prog­nostic factors on the survival rate in epithelial ovarian malignoma offers the opportunity to sur­vey the situation in Slovenia and to compare our cohort with those in cancer centres throughout the world.

Authors:
Zadnik Vesna

Keywords:
ovarian neoplasms- epidemiology, survival rate, prognosis

Cite as:
Med Razgl. 1999; 38: 521–48.

Download PDF >>
© 2021 Društvo Medicinski razgledi | Na vrh strani / To top ↑